{"id":3486,"date":"2023-03-03T17:32:28","date_gmt":"2023-03-03T16:32:28","guid":{"rendered":"https:\/\/www.access2meds.eu\/consortiu\/"},"modified":"2025-06-24T10:11:56","modified_gmt":"2025-06-24T08:11:56","slug":"consortiu","status":"publish","type":"page","link":"https:\/\/www.access2meds.eu\/ro\/consortiu\/","title":{"rendered":"Consor\u021biu"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Header” _builder_version=”4.27.4″ _module_preset=”2e264158-b54d-4d7f-8146-8c8b7ca64cef” background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1200929353_SolStock-e1679656039802.jpg” background_position=”top_center” background_last_edited=”on|phone” background_image_phone=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/06\/Mobile-Header-2.png” background_enable_image_phone=”on” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”7px|30px||30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” header_font=”|700||on|||||” header_text_color=”#E85D6B” header_font_size=”60px” custom_margin=”11px||||false|false” global_colors_info=”{}”]<\/p>\n

Consor\u021biu<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”first text colored pill” _builder_version=”4.20.0″ _module_preset=”default” background_enable_color=”off” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” vertical_offset=”-164px” custom_margin=”||-153px||false|false” custom_padding=”|0px||0px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_text_color=”#FFFFFF” text_font_size=”20px” text_line_height=”1.33em” header_2_font=”Poppins regular||||||||” header_2_text_color=”#FFFFFF” header_2_font_size=”24px” background_color=”#048EA3″ max_width=”635px” module_alignment=”left” custom_padding=”60px|92px|60px|30px|true|false” custom_css_main_element=”overflow:visible;” custom_css_after=”content:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:635px;” border_radii=”off||999px|999px|” global_colors_info=”{}”]<\/p>\n

Aceast\u0103 sec\u021biune ofer\u0103 o prezentare general\u0103 a consor\u021biului proiectului ASCERTAIN, inclusiv informa\u021bii despre partenerii proiectului \u0219i rolurile \u0219i responsabilit\u0103\u021bile acestora.<\/p>\n

Suntem un consor\u021biu de parteneri din \u0219apte \u021b\u0103ri (Austria, Belgia, \u021a\u0103rile de Jos, Slovacia, Norvegia, Germania \u0219i Italia) care colaboreaz\u0103 \u00eempreun\u0103.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”8px||36px||false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.20.2″ _module_preset=”default” custom_padding=”|30px|40px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ custom_padding=”|25px|||false|false” custom_css_main_element=”width:20.65% !important;” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/logo-erasmus-universiteit.png” title_text=”logo-erasmus-universiteit” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-erasmus-universiteit-rotterdam\/” _builder_version=”4.20.2″ _module_preset=”26b0c6d0-49a7-457d-8215-e0775d6dd853″ global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ global_colors_info=”{}”][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” text_text_color=”#393C84″ header_2_font=”Poppins semibold|||on|||||” custom_margin=”||22px||false|false” global_colors_info=”{}”]<\/p>\n

Erasmus Universiteit Rotterdam<\/h2>\n

[\/et_pb_text][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Erasmus Universiteit Rotterdam (EUR) este o universitate din Rotterdam, Olanda, cu 3.700 de membri ai personalului academic \u0219i 23.867 de studen\u021bi. Erasmus School of Health Policy & Management (ESHPM) este o \u0219coal\u0103 multidisciplinar\u0103 de cercetare \u0219i predare din cadrul universit\u0103\u021bii. Unul dintre departamentele sale, Institutul pentru evaluarea tehnologiilor medicale (iMTA), a jucat un rol-cheie \u00een cercetarea HTA \u00een Olanda, \u00een Europa \u0219i \u00een \u00eentreaga lume. Institutul a desf\u0103\u0219urat peste 600 de proiecte de cercetare \u00een domeniul asisten\u021bei medicale sponsorizate de organisme de finan\u021bare majore, cum ar fi guverne \u0219i institu\u021bii legate de guvern, Comisia European\u0103, Organiza\u021bia Mondial\u0103 a S\u0103n\u0103t\u0103\u021bii, organiza\u021bii de asisten\u021b\u0103 medical\u0103, funda\u021bii caritabile \u0219i industria farmaceutic\u0103. <\/p>\n

Rolul \u00een cadrul proiectului: <\/strong>EUR este coordonatorul acestui proiect \u0219i contribuie cu expertiz\u0103 \u00een materie de pre\u021buri, terapie genetic\u0103 \u0219i celular\u0103 \u0219i rambursare \u00een cadrul proiectului.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/www.access2meds.eu\/consortium\/team-members-erasmus-universiteit-rotterdam\/” button_text=”Vezi echipa!” _builder_version=”4.20.2″ _module_preset=”934a713e-7600-4210-b519-38aa562ec140″ button_font_last_edited=”off|desktop” global_colors_info=”{}” button_bg_enable_color__hover=”on”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.20.0″ _module_preset=”default” background_color=”#fbedec” custom_padding=”45px||45px||true|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ custom_padding=”|25px|||false|false” custom_css_main_element=”width:20.65% !important;” global_colors_info=”{}” custom_css_main_element_tablet=”width:20.65% !important;”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Comenius_University_Bratislava.svg” title_text=”Universitatea_Comenius_Bratislava” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-comenius-university-bratislava\/” _builder_version=”4.20.2″ _module_preset=”26b0c6d0-49a7-457d-8215-e0775d6dd853″ custom_padding_phone=”|0px|20px||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ global_colors_info=”{}” custom_css_main_element_tablet=”width:79.35% !important;”][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” text_text_color=”#393C84″ header_2_font=”Poppins semibold|||on|||||” header_2_line_height=”1.1em” custom_margin=”0px||22px||false|false” global_colors_info=”{}”]<\/p>\n

Comenius University in Bratislava (UNIBA)<\/h2>\n

[\/et_pb_text][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

UNIBA este o institu\u021bie de cercetare care deruleaz\u0103 sute de proiecte de cercetare na\u021bionale \u0219i interna\u021bionale. Un reprezentant al Facult\u0103\u021bii de Farmacie din cadrul Universit\u0103\u021bii Comenius din Bratislava a fost membru al Comitetului pentru rambursarea medicamentelor din cadrul Ministerului S\u0103n\u0103t\u0103\u021bii din Slovacia, \u00een numele Fondului de asigur\u0103ri de s\u0103n\u0103tate al Uniunii. <\/p>\n

Rolul \u00een cadrul proiectului:<\/strong> UNIBA ofer\u0103 expertiz\u0103 \u00een domeniul dispozitivelor medicale \u0219i al ramburs\u0103rii pentru proiect.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/www.access2meds.eu\/consortium\/team-members-comenius-university-bratislava\/” button_text=”Vezi echipa!” _builder_version=”4.20.2″ _module_preset=”934a713e-7600-4210-b519-38aa562ec140″ locked=”off” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.20.0″ _module_preset=”default” background_color=”#FFFFFF” custom_padding=”45px||45px||true|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ custom_padding=”|25px|||false|false” custom_css_main_element=”width:20.65% !important;” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/06\/wortbildmarke-goeg-RGB.png” title_text=”wortbildmarke-goeg-RGB” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-gesundheit-osterreich-gmbh\/” _builder_version=”4.25.2″ _module_preset=”26b0c6d0-49a7-457d-8215-e0775d6dd853″ max_width_phone=”200px” custom_margin=”5px||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ global_colors_info=”{}”][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” text_text_color=”#393C84″ header_2_font=”Poppins semibold|||on|||||” header_2_line_height=”1.1em” custom_margin=”||22px||false|false” global_colors_info=”{}”]<\/p>\n

Gesundheit \u00d6sterreich GmbH (GOEG)<\/h2>\n

[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Gesundheit \u00d6sterreich GmbH este institu\u021bia responsabil\u0103 cu cercetarea \u0219i planificarea asisten\u021bei medicale publice \u00een Austria. De asemenea, acesta ac\u021bioneaz\u0103 \u00een calitate de centru na\u021bional de competen\u021b\u0103 \u0219i finan\u021bare pentru promovarea s\u0103n\u0103t\u0103\u021bii \u0219i prevenire \u0219i faciliteaz\u0103 cercetarea \u00een domeniul s\u0103n\u0103t\u0103\u021bii. GOEG este o societate public\u0103, non-profit, cu r\u0103spundere limitat\u0103, de\u021binut\u0103 \u00een \u00eentregime de Republica Austria, reprezentat\u0103 de Ministerul Federal al Afacerilor Sociale, S\u0103n\u0103t\u0103\u021bii, Asisten\u021bei \u0219i Protec\u021biei Consumatorilor. <\/p>\n

Rolul \u00een cadrul proiectului:<\/strong> GOEG ofer\u0103 expertiz\u0103 \u00een stabilirea pre\u021burilor medicamentelor, \u00een politicile de stabilire a pre\u021burilor \u0219i de rambursare pentru produsele farmaceutice \u0219i dispozitivele medicale, precum \u0219i \u00een cercetarea comparativ\u0103 a sistemelor farmaceutice. Datorit\u0103 colabor\u0103rii sale cu factorii de decizie politic\u0103, GOEG contribuie, de asemenea, la schimbul de informa\u021bii \u0219i la colaborarea \u00eentre \u021b\u0103ri \u00een cadrul proiectului. <\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/www.access2meds.eu\/consortium\/team-members-gesundheit-osterreich-gmbh\/” button_text=”Vezi echipa!” _builder_version=”4.20.2″ _module_preset=”934a713e-7600-4210-b519-38aa562ec140″ button_font_last_edited=”off|desktop” global_colors_info=”{}” button_bg_enable_color__hover=”on”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.20.0″ _module_preset=”default” background_color=”rgba(57,60,132,0.15)” custom_padding=”45px||45px||true|false” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ custom_padding=”|25px|||false|false” custom_css_main_element=”width:20.65% !important;” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/university-of-oslo.png” title_text=”universitatea din-oslo” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-universitetet-i-oslo\/” _builder_version=”4.20.2″ _module_preset=”26b0c6d0-49a7-457d-8215-e0775d6dd853″ custom_margin=”5px||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ global_colors_info=”{}”][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” text_text_color=”#393C84″ header_2_font=”Poppins semibold|||on|||||” header_2_line_height=”1.1em” custom_margin=”||22px||false|false” global_colors_info=”{}”]<\/p>\n

Universitetet i Oslo <\/h2>\n

[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Universitetet i Oslo este cea mai mare \u0219i cea mai veche universitate din Norvegia. Universitatea are 27 700 de studen\u021bi \u0219i 6 000 de angaja\u021bi. Universitatea este format\u0103 din cinci facult\u0103\u021bi care desf\u0103\u0219oar\u0103 activit\u0103\u021bi de cercetare \u0219i ofer\u0103 predare \u00een teologie, drept, medicin\u0103, \u0219tiin\u021be umaniste, matematic\u0103 \u0219i \u0219tiin\u021be naturale, odontologie, \u0219i \u0219tiin\u021be sociale. Activit\u0103\u021bile de baz\u0103 ale Facult\u0103\u021bii de Medicin\u0103 sunt cercetarea, educa\u021bia, diseminarea \u0219i inovarea pentru binele pacien\u021bilor \u0219i al societ\u0103\u021bii. <\/p>\n

Rolul \u00een cadrul proiectului:<\/strong> UIO contribuie \u00een cazurile de utilizare a medicamentelor \u0219i dispozitivelor medicale pentru cancerul de precizie \u0219i cu expertiz\u0103 \u00een HTA, modelarea simul\u0103rii matematice, stabilirea priorit\u0103\u021bilor \u0219i analiza datelor din registre.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/www.access2meds.eu\/consortium\/team-members-universitetet-i-oslo\/” button_text=”Vezi echipa!” _builder_version=”4.20.2″ _module_preset=”934a713e-7600-4210-b519-38aa562ec140″ button_font_last_edited=”off|desktop” global_colors_info=”{}” button_bg_enable_color__hover=”on”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.20.0″ _module_preset=”default” background_color=”#FFFFFF” custom_padding=”45px||45px||true|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ custom_padding=”|25px|||false|false” custom_css_main_element=”width:20.65% !important;” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/AIM-LOGO_png24.png” title_text=”AIM-LOGO_png24″ url=”https:\/\/www.access2meds.eu\/consortium\/team-members-association-internationale-de-la-mutualite-aim\/” _builder_version=”4.20.2″ _module_preset=”26b0c6d0-49a7-457d-8215-e0775d6dd853″ max_width_phone=”150px” custom_margin=”5px||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#393C84″ header_2_font=”Poppins semibold|||on|||||” header_2_line_height=”1.1em” custom_margin=”||22px||false|false” global_colors_info=”{}”]<\/p>\n

The International Association of Mutual Benefit Societies (AIM)<\/h2>\n

[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

AIM serve\u0219te drept organiza\u021bie umbrel\u0103 interna\u021bional\u0103 pentru federa\u021biile de mutuale de s\u0103n\u0103tate \u0219i organismele de asigur\u0103ri de s\u0103n\u0103tate legale \u0219i complementare.
Activitatea membrilor s\u0103i se bazeaz\u0103 pe solidaritate, munc\u0103 f\u0103r\u0103 scop lucrativ \u0219i democra\u021bie \u00een Europa, America Latin\u0103, Africa \u0219i Orientul Mijlociu.
AIM pledeaz\u0103 pentru acces egal la s\u0103n\u0103tate \u0219i \u00eengrijire, pre\u021buri corecte pentru medicamente, o digitalizare care s\u0103 serveasc\u0103 asigura\u021bilor, integrarea s\u0103n\u0103t\u0103\u021bii \u00een toate politicile \u0219i un accent mai puternic pe prevenire.<\/p>\n

Rolul \u00een cadrul proiectului:<\/strong> Algoritmul inovator care combin\u0103 accesibilitatea \u0219i sprijinul pentru inovarea valoroas\u0103 va sta la baza modelului inovator de stabilire a pre\u021burilor \u00een ASCERTAIN.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/www.access2meds.eu\/consortium\/team-members-association-internationale-de-la-mutualite-aim\/” button_text=”Vezi echipa!” _builder_version=”4.20.2″ _module_preset=”934a713e-7600-4210-b519-38aa562ec140″ button_font_last_edited=”off|desktop” global_colors_info=”{}” button_bg_enable_color__hover=”on”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” background_color=”rgba(133,184,189,0.3)” custom_padding=”45px||45px||true|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ custom_padding=”|25px|||false|false” custom_css_main_element=”width:20.65% !important;” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/08\/Logo-EHA-Black.png” title_text=”Logo EHA – Negru” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-european-hematology-association\/” _builder_version=”4.27.0″ _module_preset=”26b0c6d0-49a7-457d-8215-e0775d6dd853″ max_width_phone=”150px” custom_margin=”||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ global_colors_info=”{}”][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” text_text_color=”#393C84″ header_2_font=”Poppins semibold|||on|||||” header_2_line_height=”1.1em” custom_margin=”||22px||false|false” global_colors_info=”{}”]<\/p>\n

European Hematology Association <\/h2>\n

[\/et_pb_text][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

European Hematology Association (EHA) – EHA este o organiza\u021bie neguvernamental\u0103 \u0219i non-profit, ghidat\u0103 de misiunea sa de a promova excelen\u021ba \u00een \u00eengrijirea pacien\u021bilor, cercetarea \u0219i educa\u021bia \u00een hematologie. EHA este cea mai mare organiza\u021bie european\u0103 care reune\u0219te cadre medicale, cercet\u0103tori \u0219i oameni de \u0219tiin\u021b\u0103 interesa\u021bi de hematologie. EHA reprezint\u0103 hematologia \u0219i hematologii \u00een arena politic\u0103 european\u0103 pentru \u00eembun\u0103t\u0103\u021birea reglement\u0103rilor, cre\u0219terea disponibilit\u0103\u021bii \u0219i accesibilit\u0103\u021bii medicamentelor \u0219i armonizarea educa\u021biei \u0219i form\u0103rii hematologilor. <\/p>\n

Rolul \u00een cadrul proiectului:<\/strong> contribuie cu expertiz\u0103 la stabilirea pre\u021burilor \u0219i a raportului cost-eficacitate \u00een cadrul proiectului.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/www.access2meds.eu\/consortium\/team-members-european-hematology-association\/” button_text=”Vezi echipa!” _builder_version=”4.20.2″ _module_preset=”934a713e-7600-4210-b519-38aa562ec140″ button_font_last_edited=”off|desktop” global_colors_info=”{}” button_bg_enable_color__hover=”on”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.20.0″ _module_preset=”default” background_color=”#FFFFFF” custom_padding=”45px||45px||true|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ custom_padding=”|25px|||false|false” custom_css_main_element=”width:20.65% !important;” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Chino.io-logo.png” title_text=”Chino.io – logo” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-chino-srl\/” _builder_version=”4.20.2″ _module_preset=”26b0c6d0-49a7-457d-8215-e0775d6dd853″ custom_margin=”||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ global_colors_info=”{}”][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” text_text_color=”#393C84″ header_2_font=”Poppins semibold|||on|||||” header_2_line_height=”1.1em” custom_margin=”||22px||false|false” global_colors_info=”{}”]<\/p>\n

Chino.io (CHINO)<\/h2>\n

[\/et_pb_text][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Chino SRL este o companie italian\u0103 de securitate cibernetic\u0103 \u0219i tehnologie cloud \u00eenfiin\u021bat\u0103 \u00een 2014 cu misiunea de a ajuta dezvoltatorii de aplica\u021bii de s\u0103n\u0103tate s\u0103 rezolve problemele de securitate \u0219i de conformitate cu legisla\u021bia privind confiden\u021bialitatea atunci c\u00e2nd au de-a face cu date medicale sensibile \u00een cloud. Chino SRL a creat o platform\u0103 de dezvoltare software denumit\u0103 Chino.io. Platforma ofer\u0103 dezvoltatorilor un set de API-uri pentru a stoca, partaja \u0219i gestiona \u00een siguran\u021b\u0103 datele medicale sensibile \u0219i pentru a respecta pe deplin toate legile privind protec\u021bia datelor, inclusiv GDPR, ePrivacy \u0219i HIPAA. <\/p>\n

Rolul \u00een cadrul proiectului:<\/strong> <\/span><\/strong>Gestionarea datelor \u0219i etic\u0103 \u00een cadrul WP2.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/www.access2meds.eu\/consortium\/team-members-chino-srl\/” button_text=”Vezi echipa!” _builder_version=”4.20.2″ _module_preset=”934a713e-7600-4210-b519-38aa562ec140″ button_font_last_edited=”off|desktop” global_colors_info=”{}” button_bg_enable_color__hover=”on”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.20.0″ _module_preset=”default” background_color=”#fbedec” custom_padding=”45px||45px||true|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ custom_padding=”|25px|||false|false” custom_css_main_element=”width:20.65% !important;” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/MPE-Logo.png” title_text=”Logo-ul MPE” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-myeloma-patients-europe-aisbl\/” _builder_version=”4.20.2″ _module_preset=”26b0c6d0-49a7-457d-8215-e0775d6dd853″ max_width_phone=”100px” custom_margin=”||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ global_colors_info=”{}”][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” text_text_color=”#393C84″ header_2_font=”Poppins semibold|||on|||||” header_2_line_height=”1.1em” custom_margin=”||22px||false|false” global_colors_info=”{}”]<\/p>\n

Myeloma Patients Europe (MPE)<\/h2>\n

[\/et_pb_text][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Myeloma Patients Europe (MPE) este o organiza\u021bie umbrel\u0103 a grupurilor de pacien\u021bi cu mielom multiplu \u0219i amiloidoz\u0103 AL din Europa. \u00cen prezent, MPE are 53 de membri din 33 de \u021b\u0103ri. Misiunea organiza\u021biei este de a oferi educa\u021bie, informa\u021bii \u0219i sprijin grupurilor membre \u0219i de a advoca la nivel european, na\u021bional \u0219i local pentru cea mai bun\u0103 cercetare posibil\u0103 \u0219i acces egal la tratament \u0219i \u00eengrijire. Pentru a-\u0219i atinge obiectivele, MPE colaboreaz\u0103 direct cu membrii s\u0103i, profesioni\u0219tii din domeniul s\u0103n\u0103t\u0103\u021bii, autorit\u0103\u021bile de rambursare, autorit\u0103\u021bile de reglementare, politicienii, companiile farmaceutice \u0219i mass-media pentru a se asigura c\u0103 toate p\u0103r\u021bile interesate colaboreaz\u0103 \u00een vederea \u00eembun\u0103t\u0103\u021birii rezultatelor pentru pacien\u021bi \u0219i a reducerii inegalit\u0103\u021bilor \u00een \u00eentreaga Europ\u0103. <\/p>\n

Rolul \u00een cadrul proiectului:<\/strong> implicarea pacien\u021bilor, identificarea nevoilor \u0219i preferin\u021belor pacien\u021bilor pentru dezvoltarea modelelor.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/www.access2meds.eu\/consortium\/team-members-myeloma-patients-europe-aisbl\/” button_text=”Vezi echipa!” _builder_version=”4.20.2″ _module_preset=”934a713e-7600-4210-b519-38aa562ec140″ button_font_last_edited=”off|desktop” global_colors_info=”{}” button_bg_enable_color__hover=”on”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” custom_padding=”45px||45px||true|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ custom_padding=”|25px|||false|false” custom_css_main_element=”width:20.65% !important;” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/OptiMedis_RGB.svg” title_text=”OptiMedis_RGB” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-optimedis-ag\/” _builder_version=”4.20.2″ _module_preset=”26b0c6d0-49a7-457d-8215-e0775d6dd853″ max_width_phone=”130px” custom_margin=”||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.20.2″ _module_preset=”f72966c0-c6ca-409f-a2c1-5e5bf3d89104″ global_colors_info=”{}”][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” text_text_color=”#393C84″ header_2_font=”Poppins semibold|||on|||||” header_2_line_height=”1.1em” custom_margin=”||22px||false|false” global_colors_info=”{}”]<\/p>\n

OptiMedis AG (OM)<\/h2>\n

[\/et_pb_text][et_pb_text _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

OptiMedis este o societate de management \u0219i analiz\u0103 a datelor medicale \u00eenregistrat\u0103 \u00een Germania. Activitatea sa principal\u0103 const\u0103 \u00een dezvoltarea \u0219i gestionarea sistemelor regionale integrate de furnizare a asisten\u021bei medicale cu re\u021bele de medici \u0219i al\u021bi furnizori. Abordarea OptiMedis de transformare a sistemelor de asisten\u021b\u0103 medical\u0103 a fost recunoscut\u0103 frecvent de UE, de mai multe proiecte de cercetare ale UE, de Commonwealth Fund, Duke Margolis Centre for Health Policy, OMS, Banca Mondial\u0103 \u0219i al\u021bii. OptiMedis gestioneaz\u0103 trei sisteme integrate de furnizare a asisten\u021bei medicale \u00een Germania, cu o popula\u021bie de peste 120 000 de persoane \u0219i care implic\u0103 peste 150 de furnizori de asisten\u021b\u0103 medical\u0103. OptiMedis este implicat\u0103 \u00een prezent \u00een proiecte competitive de cercetare \u0219i implementare cu un volum de peste 10 milioane de euro. <\/p>\n

Rolul \u00een cadrul proiectului: <\/strong>Activit\u0103\u021bi de diseminare \u0219i exploatare a proiectului, fabricarea ecologic\u0103 a tehnologiilor medicale.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/www.access2meds.eu\/consortium\/team-members-optimedis-ag\/” button_text=”Vezi echipa!” button_alignment=”left” _builder_version=”4.20.2″ _module_preset=”934a713e-7600-4210-b519-38aa562ec140″ button_bg_color=”RGBA(255,255,255,0)” custom_padding_last_edited=”off|phone” button_font_last_edited=”off|desktop” global_colors_info=”{}” button_bg_enable_color__hover=”on”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”contact” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#86B8BD” custom_margin=”||||false|false” custom_padding=”16px||75px||false|false” box_shadow_style=”preset7″ box_shadow_horizontal=”0px” box_shadow_vertical=”-274px” box_shadow_color=”#FFFFFF” global_module=”910″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” header_font=”Poppins semibold|||on|||||” header_font_size=”36px” custom_margin=”14px||23px||false|false” custom_margin_tablet=”” custom_margin_phone=”||30px||false|false” custom_margin_last_edited=”on|phone” header_font_size_phone=”24px” global_colors_info=”{}”]<\/p>\n

Persoan\u0103 de contact<\/h1>\n

[\/et_pb_text][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”Poppins regular||||||||” text_text_color=”#393C84″ text_font_size=”24px” text_line_height=”1.33em” module_alignment=”right” custom_margin=”||0px||false|false” text_font_size_tablet=”” text_font_size_phone=”18px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n

V\u0103 rug\u0103m s\u0103 lua\u021bi leg\u0103tura cu noi dac\u0103 ave\u021bi \u00eentreb\u0103ri sau comentarii! V\u0103 vom r\u0103spunde c\u00e2t mai cur\u00e2nd posibil. <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ use_custom_gutter=”on” module_class=”tablet-three-cols” _builder_version=”4.20.2″ _module_preset=”default” max_width_tablet=”980px” max_width_phone=”500px” max_width_last_edited=”on|phone” custom_padding=”0px|30px|0px|30px|false|true” global_colors_info=”{}” custom_css_main_element_last_edited=”on|phone” custom_css_main_element_tablet=”display:flex;” custom_css_main_element_phone=”display:flex; flex-direction:column;”][et_pb_column type=”1_3″ _builder_version=”4.20.2″ _module_preset=”be0fba28-f74a-4ba0-9a8d-9cd30aca805d” global_colors_info=”{}” custom_css_main_element_last_edited=”on|tablet” custom_css_main_element_tablet=”margin-bottom:0;” custom_css_main_element_phone=”margin-bottom:20px;”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Carin_Uyl-de-Groot.png” title_text=”Carin_Uyl-de-Groot” _builder_version=”4.20.2″ _module_preset=”a348f9e0-d57b-4c22-b522-c52b784fe57f” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_text_color=”#FFFFFF” link_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n

Pentru \u00eentreb\u0103ri legate de cercetare:<\/p>\n

Carin Uyl-de Groot<\/strong>
Coordonator de proiect<\/p>\n

Universitatea Erasmus din Rotterdam
uyl@eshpm.eur.nl<\/a>
Telefon: +31 10 4081583<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.20.2″ _module_preset=”be0fba28-f74a-4ba0-9a8d-9cd30aca805d” background_color=”#393C84″ global_colors_info=”{}” custom_css_main_element_last_edited=”on|phone” custom_css_main_element_tablet=”margin-bottom:0;” custom_css_main_element_phone=”margin-bottom:20px;”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Marcel-Langone-1.png” title_text=”Marcel-Langone” align=”center” _builder_version=”4.20.2″ _module_preset=”a348f9e0-d57b-4c22-b522-c52b784fe57f” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_text_color=”#FFFFFF” link_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n

Pentru \u00eentreb\u0103ri generale legate de proiect:<\/p>\n

Marcel Langone Marques<\/strong>
Manager de proiect<\/p>\n

Universitatea Erasmus din Rotterdam
marcel.langonemarques@eur.nl<\/a>
Telefon: +31 10 4081583<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.20.2″ _module_preset=”be0fba28-f74a-4ba0-9a8d-9cd30aca805d” background_color=”#048EA3″ global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/06\/My-project-1-7.png” title_text=”Proiectul meu-1 (7)” _builder_version=”4.21.0″ _module_preset=”a348f9e0-d57b-4c22-b522-c52b784fe57f” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_text_color=”#FFFFFF” link_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n

Pentru comunica\u021bii:<\/p>\n

Lena Jessen<\/strong>
Manager de proiect<\/p>\n

OptiMedis
l.jessen@optimedis.de<\/a>
Telefon: +49 40 226211490<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

Consor\u021biuAceast\u0103 sec\u021biune ofer\u0103 o prezentare general\u0103 a consor\u021biului proiectului ASCERTAIN, inclusiv informa\u021bii despre partenerii proiectului \u0219i rolurile \u0219i responsabilit\u0103\u021bile acestora. Suntem un consor\u021biu de parteneri din \u0219apte \u021b\u0103ri (Austria, Belgia, \u021a\u0103rile de Jos, Slovacia, Norvegia, Germania \u0219i Italia) care colaboreaz\u0103 \u00eempreun\u0103.Erasmus Universiteit RotterdamErasmus Universiteit Rotterdam (EUR) este o universitate din Rotterdam, Olanda, cu 3.700 de membri ai personalului academic \u0219i 23.867 de studen\u021bi. Erasmus School of Health Policy & Management (ESHPM) este o \u0219coal\u0103 multidisciplinar\u0103 de cercetare \u0219i predare din cadrul universit\u0103\u021bii. Unul dintre departamentele sale, Institutul pentru evaluarea tehnologiilor medicale (iMTA), a jucat un rol-cheie \u00een cercetarea HTA \u00een Olanda, \u00een Europa \u0219i \u00een \u00eentreaga lume. Institutul a desf\u0103\u0219urat peste 600 de proiecte de cercetare \u00een domeniul asisten\u021bei medicale sponsorizate de organisme de finan\u021bare majore, cum ar fi guverne \u0219i institu\u021bii legate de guvern, Comisia European\u0103, Organiza\u021bia Mondial\u0103 a S\u0103n\u0103t\u0103\u021bii, organiza\u021bii de asisten\u021b\u0103 medical\u0103, funda\u021bii caritabile \u0219i industria farmaceutic\u0103. Rolul \u00een cadrul proiectului: EUR este coordonatorul acestui proiect \u0219i contribuie cu expertiz\u0103 \u00een materie de pre\u021buri, terapie genetic\u0103 \u0219i celular\u0103 \u0219i rambursare \u00een cadrul proiectului.Comenius University in Bratislava (UNIBA)UNIBA este o institu\u021bie de cercetare care deruleaz\u0103 sute de proiecte de cercetare na\u021bionale \u0219i interna\u021bionale. Un reprezentant al Facult\u0103\u021bii de […]<\/p>\n","protected":false},"author":1,"featured_media":2556,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-3486","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nConsor\u021biu - ASCERTAIN<\/title>\n<meta name=\"description\" content=\"Proiectul ASCERTAIN reune\u0219te zece parteneri din \u0219apte \u021b\u0103ri - Austria, Belgia, \u021a\u0103rile de Jos, Slovacia, Norvegia, Germania \u0219i Italia.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/ro\/consortiu\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Consor\u021biu\" \/>\n<meta property=\"og:description\" content=\"Proiectul ASCERTAIN reune\u0219te zece parteneri din \u0219apte \u021b\u0103ri - Austria, Belgia, \u021a\u0103rile de Jos, Slovacia, Norvegia, Germania \u0219i Italia.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/ro\/consortiu\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-24T08:11:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1093935162_iStock_Rawpixel.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1254\" \/>\n\t<meta property=\"og:image:height\" content=\"836\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data1\" content=\"22 de minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/consortiu\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/consortiu\\\/\",\"name\":\"Consor\u021biu - ASCERTAIN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/consortiu\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/consortiu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Foto_1093935162_iStock_Rawpixel.jpg\",\"datePublished\":\"2023-03-03T16:32:28+00:00\",\"dateModified\":\"2025-06-24T08:11:56+00:00\",\"description\":\"Proiectul ASCERTAIN reune\u0219te zece parteneri din \u0219apte \u021b\u0103ri - Austria, Belgia, \u021a\u0103rile de Jos, Slovacia, Norvegia, Germania \u0219i Italia.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/consortiu\\\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/consortiu\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/consortiu\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Foto_1093935162_iStock_Rawpixel.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Foto_1093935162_iStock_Rawpixel.jpg\",\"width\":1254,\"height\":836},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/consortiu\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/startseite\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Consor\u021biu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Consor\u021biu - ASCERTAIN","description":"Proiectul ASCERTAIN reune\u0219te zece parteneri din \u0219apte \u021b\u0103ri - Austria, Belgia, \u021a\u0103rile de Jos, Slovacia, Norvegia, Germania \u0219i Italia.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/ro\/consortiu\/","og_locale":"ro_RO","og_type":"article","og_title":"Consor\u021biu","og_description":"Proiectul ASCERTAIN reune\u0219te zece parteneri din \u0219apte \u021b\u0103ri - Austria, Belgia, \u021a\u0103rile de Jos, Slovacia, Norvegia, Germania \u0219i Italia.","og_url":"https:\/\/www.access2meds.eu\/ro\/consortiu\/","og_site_name":"ASCERTAIN","article_modified_time":"2025-06-24T08:11:56+00:00","og_image":[{"width":1254,"height":836,"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1093935162_iStock_Rawpixel.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Timp estimat pentru citire":"22 de minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/ro\/consortiu\/","url":"https:\/\/www.access2meds.eu\/ro\/consortiu\/","name":"Consor\u021biu - ASCERTAIN","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/ro\/consortiu\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/ro\/consortiu\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1093935162_iStock_Rawpixel.jpg","datePublished":"2023-03-03T16:32:28+00:00","dateModified":"2025-06-24T08:11:56+00:00","description":"Proiectul ASCERTAIN reune\u0219te zece parteneri din \u0219apte \u021b\u0103ri - Austria, Belgia, \u021a\u0103rile de Jos, Slovacia, Norvegia, Germania \u0219i Italia.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/ro\/consortiu\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/ro\/consortiu\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/www.access2meds.eu\/ro\/consortiu\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1093935162_iStock_Rawpixel.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1093935162_iStock_Rawpixel.jpg","width":1254,"height":836},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/ro\/consortiu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/ro\/startseite\/"},{"@type":"ListItem","position":2,"name":"Consor\u021biu"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/pages\/3486","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/comments?post=3486"}],"version-history":[{"count":17,"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/pages\/3486\/revisions"}],"predecessor-version":[{"id":4519,"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/pages\/3486\/revisions\/4519"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/media\/2556"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/media?parent=3486"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}